SDPS-37 IDENTIFICATION OF TIME-COURSE RELATED, TREATMENT-RELATED, AND PATIENT-RELATED PROGNOSTIC FACTORS IN BRAF-MUTANT MELANOMA BRAIN METASTASES.

PURPOSE: Patients with BRAF-mutant melanoma brain metastases (MBM) continue to have limited overall survival (OS), averaging 4 months, despite advancements in systemic therapies. Our study aims to identify patient-specific and treatment-related prognostic factors in BRAF-mutant MBM to inform treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Erickson, Lily G, Ramaswamy, Sahana, Ferguson, Sherise D, Long, James, Hasanov, Merve, Davies, Alicia Bea, Sirmans, Elizabeth, Saberian, Chantal, Posada, Eliza L, Malke, Jared, Haydu, Lauren E, Tawbi, Hussein, Chung, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Screening/Diagnostics/Prognostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402308/
http://dx.doi.org/10.1093/noajnl/vdad070.091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402308/
http://dx.doi.org/10.1093/noajnl/vdad070.091

Ejemplares similares